The drugmaker also tested its antibody treatment against, B.1.1.7, the variant first identified in the U.K., finding it to be just as effective as it had been against earlier versions of the novel coronavirus.
The studies were not conducted using humans, but rather a manufactured pseudovirus containing mutations found in the two variants. The researchers found that the variant discovered in South Africa affected a wider range of antibodies.
More articles on pharmacy:
US drug prices 256% higher than other countries, study shows
Oklahoma trying to give back $2M hydroxychloroquine stockpile
Most pregnant women shouldn’t get COVID-19 vaccines, WHO says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
